In this context, mast cells and other immunocytes would find their tissue milieu to be enriched for insulin chronically, and so the reprogramming of mast cells that we observe in vitro and in vivo has potential relevance to inflammatory responses in patients with MS [6]. Here, INS is linked to myeloid sarcoma.